Systematic review of risk factors of hepatocellular carcinoma after hepatitis B surface antigen seroclearance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Systematic review of risk factors of hepatocellular carcinoma after hepatitis B surface antigen seroclearance

Published:2018-05-02 Issue:9 Volume:25 Page:1026-1037
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Kuang X.-J.¹,Jia R.-R.²,Huo R.-R.³,Yu J.-J.⁴,Wang J.-J.¹,Xiang B.-D.³,Li L.-Q.³,Peng Z.¹,Zhong J.-H.³^ORCID

Affiliation:

1. Department of Hepatobiliary Surgery; The Affiliated Hospital of Xiangnan University; Chenzhou China

2. Department of Basic Research; Affiliated Tumor Hospital of Guangxi Medical University; Nanning China

3. Department of Hepatobiliary Surgery; Affiliated Tumor Hospital of Guangxi Medical University; Nanning China

4. Department of Clinical Medicine; Second Military Medical University; Shanghai China

Funder

Self-Raised Scientific Research Fund of the Ministry of Health of Guangxi Province

Graduate Course Construction Project of Guangxi Medical University

Young Teachers in Guangxi Universities

Hunan Science and Technology Development Projects

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvh.12905/fullpdf

Reference64 articles.

1. Hepatitis B surface antigen levels after hepatitis B e-antigen seroclearance: a longitudinal follow-up study;Fung;Liver Int,2015

2. Distinct seromarkers predict different milestones of chronic hepatitis B progression;Liu;Hepatology,2014

3. Natural history of chronic HBV carriers in northern Italy: morbidity and mortality after 30 years;Manno;Gastroenterology,2004

4. Systematic review with meta-analysis: development of hepatocellular carcinoma in chronic hepatitis B patients with hepatitis B surface antigen seroclearance;Liu;Aliment Pharmacol Ther,2016

5. Letter: clinical outcomes of HBsAg loss in chronic HBV infection;Zhao;Aliment Pharmacol Ther,2016

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of integrated hepatitis B virus DNA on oncogenesis and antiviral therapy;Biomarker Research;2024-08-15

2. Letter: Determining optimal ALT cut‐off values for predicting significant hepatic histological changes in chronic hepatitis B virus infection;Alimentary Pharmacology & Therapeutics;2024-04-09

3. Should Indications for Antiviral Therapy for Hepatitis B Be Broadened to Include Immune-Tolerant Patients, Inactive Carriers, or Patients in the “Gray Zone”?;Current Hepatology Reports;2024-02-12

4. Entecavir versus tenofovir for prevention of hepatitis B virus-associated hepatocellular carcinoma after curative resection: study protocol for a randomized, open-label trial;Trials;2024-01-05

5. Anti-HBc: a significant host predictor of spontaneous HBsAg seroclearance in chronic hepatitis B patients - a retrospective longitudinal study;BMC Gastroenterology;2023-10-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3